Trial Profile
Coagulation effect of sugammadex using thromboelastography in a randomized controlled study of surgical patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2018
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Glycopyrrolate; Pyridostigmine
- Indications Neuromuscular blockade
- Focus Pharmacodynamics
- 21 Feb 2018 Planned number of patients changed from 40 to 60.
- 21 Feb 2018 Status changed from recruiting to completed.
- 29 Sep 2016 New trial record